Following the success of the kick-off meeting previously held in Bristol, the MagnaPharm consortium descended upon the University of Limerick to discuss progress and share early discoveries amongst the group. MagnaPharm (Magnetic Control of Polymorphism in Pharmaceutical Compounds) is a H2020 FETOPEN award between the University of Bristol, University College London, Radboud University and Limerick University, initiating a major international effort to direct polymorphism in pharmaceutical compounds through crystallizing in high magnetic fields.
The group met informally on arrival in Limerick, which for most was the first visit to the University. New group members were welcomed to the consortium over an evening meal, convening the following day (19th July 2017) for more scientific discussions.
Hosted by Prof Ursel Bangert, the group was delighted to be taken on a tour of the world-class Titan Themis Electron Microscope recently launched at the University.
Professor Ursel Bangert, gave an animated talk on ‘Mad Atoms Tea Party’…
The invited speakers of the MSI2015 symposium in Limerick offered a broad…
Following the success of the kick-off meeting previously held in Bristol, the…